35 research outputs found

    Exploring Students with Disabilities Experiences in the Classroom at a Midwestern Community College

    Get PDF
    This exploratory study featured interviews with students’ with disabilities at a Midwestern Community College. The interviews were created with the guiding research question: What are students’ with disabilities experiences with faculty at Midwestern Community College? Five participants were identified using convenient sampling. Interviews were held via zoom using semi-structured questions that aimed to gain an understanding of students’ experiences with faculty with an emphasis on Universal Design. Participants’ unique narratives provided a wealth of information about their individual experiences, which were transcribed and analyzed using inductive coding and analysis. The findings from this study emphasize the importance of communication, technology, flexibility, structure with an overarching meta-theme of COVID-19, which amplified the other findings, have had on students’ with disabilities experience with faculty. Students indicated both items the students themselves can practice, along with faculty, in order to cultivate a more inclusive education setting for students with disabilities in higher education. Findings have been presented to the Midwestern Community College Disability Support office and will inform ongoing efforts for equitable education

    Editorial: Why should we read Dalit literature?

    Get PDF
    <p>(A) BDNF and (B) NCAM1 expression in the VTA of mice exposed to ABA conditions. Insets indicate mean BDNF and NCAM1 expression during restriction for the independent measure depicted. Results expressed as mean log2(RQ) ± S.E.M. p<0.05. STV, starved mice exposed to food restriction and house without a wheel; RUN, mice exposed to wheel running; ABA, mice exposed to ABA conditions; W, wheel; FR, food restriction.</p

    Effects of ABA paradigm on behavior.

    No full text
    <p>(A) Survival, (B) daily body weight, (C) food intake, and (D) wheel running during food restriction. Numbers in italics depict number of mice remaining in the ABA paradigm. Results expressed as mean ± SEM. BL, baseline; STV, starved mice exposed to food restriction and house without a wheel; RUN, mice exposed to wheel running; ABA, mice exposed to ABA conditions.</p

    Activity-Based Anorexia Alters the Expression of BDNF Transcripts in the Mesocorticolimbic Reward Circuit

    No full text
    <div><p>Anorexia nervosa (AN) is a complex eating disorder with severe dysregulation of appetitive behavior. The activity-based anorexia (ABA) paradigm is an animal model in which rodents exposed to both running wheels and scheduled feeding develop aspects of AN including paradoxical hypophagia, dramatic weight loss, and hyperactivity, while animals exposed to only one condition maintain normal body weight. Brain-derived neurotrophic factor (BDNF), an activity-dependent modulator of neuronal plasticity, is reduced in the serum of AN patients, and is a known regulator of feeding and weight maintenance. We assessed the effects of scheduled feeding, running wheel access, or both on the expression of BDNF transcripts within the mesocorticolimbic pathway. We also assessed the expression of neuronal cell adhesion molecule 1 (NCAM1) to explore the specificity of effects on BDNF within the mesocorticolimbic pathway. Scheduled feeding increased the levels of both transcripts in the hippocampus (HPC), increased NCAM1 mRNA expression in the ventral tegmental area (VTA), and decreased BDNF mRNA levels in the medial prefrontal cortex (mPFC). In addition, wheel running increased BDNF mRNA expression in the VTA. No changes in either transcript were observed in the nucleus accumbens (NAc). Furthermore, no changes in either transcript were induced by the combined scheduled feeding and wheel access condition. These data indicate that scheduled feeding or wheel running alter BDNF and NCAM1 expression levels in specific regions of the mesocorticolimbic pathway. These findings contribute to our current knowledge of the molecular alterations induced by ABA and may help elucidate possible mechanisms of AN pathology.</p></div

    Baseline dependent measures.

    No full text
    <p>Body weight, food intake, and wheel running during baseline in mice housed with and without running wheels. Mean ± S.E.M.</p

    Serotonin 2C receptor antagonists induce fast-onset antidepressant effects

    No full text
    Current antidepressants must be administered for several weeks to produce therapeutic effects. We show that selective serotonin 2C (5-HT2C) antagonists exert antidepressant actions with a faster-onset (5 days) than that of current antidepressants (14 days) in mice. Subchronic (5 days) treatment with 5-HT2C antagonists induced antidepressant behavioral effects in the chronic forced swim test (cFST), chronic mild stress (CMS) paradigm and olfactory bulbectomy paradigm. This treatment regimen also induced classical markers of antidepressant action: activation of cAMP response element-binding protein (CREB) and induction of brain-derived neurotrophic factor (BDNF) in the medial prefrontal cortex (mPFC). None of these effects were induced by subchronic treatment with citalopram, a prototypical selective serotonin reuptake inhibitor (SSRI). Local infusion of 5-HT2C antagonists into the ventral tegmental area was sufficient to induce BDNF in the mPFC, and dopamine D1 receptor antagonist treatment blocked the antidepressant behavioral effects of 5-HT2C antagonists. 5-HT2C antagonists also activated mammalian target of rapamycin (mTOR) and eukaryotic elongation factor 2 (eEF2) in the mPFC, effects recently linked to rapid antidepressant action. Furthermore, 5-HT2C antagonists reversed CMS-induced atrophy of mPFC pyramidal neurons. Subchronic SSRI treatment, which does not induce antidepressant behavioral effects, also activated mTOR and eEF2 and reversed CMS-induced neuronal atrophy, indicating that these effects are not sufficient for antidepressant onset. Our findings reveal that 5-HT2C antagonists are putative fast-onset antidepressants, which act through enhancement of mesocortical dopaminergic signaling.This work was funded by National Institutes of Health Grants RO1MH079424, T32GM07839, a NARSAD Young Investigator Award to SD and The Geraldi Norton Foundation
    corecore